This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

RemitDATA Launching Focused Comparative Analytics Solution For HME Market At Medtrade

PLANO, Texas, Oct. 12, 2012 /PRNewswire/ -- RemitDATA Inc., the healthcare industry's leading provider of comparative analytics for provider productivity and financial data, today announced that it is expanding its market for TITAN® to the Home Medical Equipment (HME) marketplace with a launch at Medtrade 2012 in Atlanta, Georgia.

"Because of our long history in the Home Medical Equipment market, we understand providers are under tremendous pressure to participate in competitive bidding and better manage audits from a myriad of government programs," stated Michael Sanderson, president, RemitDATA. "With TITAN, HME companies now have access to real-time comparative analysis that enables them to prepare for and cope with competitive bidding, high denials and government audits that, if not managed properly, can have serious implications for the survival of a business."

TITAN, a first-of-its-kind data-rich solution that provides a level of reimbursement and utilization comparative analysis only available previously to payers, Medicare and regulators, was launched nearly two years ago to provide real-time analytics for physicians and billing companies. Since that time, TITAN has been adopted by some of the largest healthcare IT companies in the industry.

TITAN continues to be the only solution in the ambulatory and HME/DME markets offering real-time comparative analysis and custom benchmarking that enables providers to compare themselves against their peers based on specialty and geography. Through robust data analysis, providers also have access to key business indicators needed to identify focus areas such as how to accelerate cash flow, lower denial rates, track payer performance and correct billing errors.

"We realized that the needs of the HME market are no different than other healthcare providers in that they stand to benefit most when data is available in real time and easy to view, understand, use and share," Sanderson noted. "For over a decade, we have provided HME companies with valuable document management and denial management solutions. Now, we're providing them the comparative analytics they need in order to successfully enter the competitive bidding process and to track their claims and utilization to better prepare for government audits. No other company in the HME/DME market can offer the breadth and depth of data necessary to power these comparative analytics."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs